Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BNTC Benitec Biopharma Limited

0.12 (3.92%)
Nov 30 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 7,343
Bid Price 0.32
Ask Price 4.17
News (1)
Day High 3.47


52 Week Range


Day Low 3.06
Company Name Stock Ticker Symbol Market Type
Benitec Biopharma Limited BNTC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.12 3.92% 3.18 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.06 3.06 3.47 3.18 3.06
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
143 7,343 $ 3.28 $ 24,104 - 1.86 - 9.01
Last Trade Time Type Quantity Stock Price Currency
16:00:00 9 $ 3.23 USD

Benitec Biopharma Limited Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.18M - - - 202.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Benitec Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No BNTC Message Board. Create One! See More Posts on BNTC Message Board See More Message Board Posts

Historical BNTC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.313.482.993.139,625-0.13-3.93%
1 Month3.703.992.993.548,545-0.52-14.05%
3 Months3.183.992.78663.2315,6220.000.0%
6 Months4.259.011.865.451,951,258-1.07-25.18%
1 Year3.749.011.865.211,172,003-0.56-14.97%
3 Years49.98178.331.8645.22916,495-46.80-93.64%
5 Years35.19295.61981.8646.67580,957-32.01-90.96%

Benitec Biopharma Description

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV).

Your Recent History

Delayed Upgrade Clock